Hyogo, Japan

Keiji Iwamoto


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiji Iwamoto: Innovator in Biotechnological Advancements

Introduction

Keiji Iwamoto is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of hybridomas for producing biologically active substances. His work has implications for industrial production and advancements in medical research.

Latest Patents

Iwamoto holds a patent for a fibroblast growth factor gene transformed hybridoma. This patent includes a hybridoma that carries a vector for expressing a fibroblast growth factor (FGF) protein gene. The patent also outlines a method for producing this hybridoma and a method for cultivating it to produce biologically active substances efficiently. This innovation is particularly advantageous for industrial production, as it allows for the recovery of biologically active substances using serum-free mediums.

Career Highlights

Keiji Iwamoto is associated with Takeda Chemical Industries, Inc., where he has contributed to various research initiatives. His work has focused on enhancing the production of biologically active substances, which are crucial for therapeutic applications. His innovative approaches have positioned him as a key figure in the biotechnology sector.

Collaborations

Iwamoto has collaborated with notable colleagues, including Hidekazu Sawada and Kazuaki Kitano. These collaborations have fostered advancements in their shared research interests and have contributed to the success of their projects.

Conclusion

Keiji Iwamoto's contributions to biotechnology, particularly through his patented innovations, highlight his role as a significant inventor in the field. His work continues to influence the production of biologically active substances, showcasing the importance of innovation in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…